Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,292 | -40,532 | -20,093 | -17,006 | -18,493 |
| Depreciation Amortization | 1,320 | 606 | 258 | 215 | 320 |
| Accounts receivable | -1,410 | N/A | N/A | 0 | 1,075 |
| Accounts payable and accrued liabilities | 525 | 943 | -118 | 493 | -367 |
| Other Working Capital | 101,068 | 2,714 | -1,520 | 873 | 391 |
| Other Operating Activity | 4,980 | 1,684 | 728 | 29 | -213 |
| Operating Cash Flow | $89,192 | $-34,585 | $-20,745 | $-15,396 | $-17,287 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,863 | -235 | -201 | -155 | -460 |
| Purchase Of Investment | -265,204 | -236,930 | -12,296 | -35,497 | -19,457 |
| Sale Of Investment | 163,671 | 169,854 | 27,507 | 33,786 | 15,489 |
| Investing Cash Flow | $-103,395 | $-67,311 | $15,011 | $-1,866 | $-4,428 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 3,591 | 22,898 | 0 | 4,931 |
| Debt Repayment | -13,544 | -2,708 | -9,138 | -5,519 | -705 |
| Common Stock Issued | 391 | 145,498 | 147 | 0 | 46 |
| Other Financing Activity | 0 | 0 | 0 | 26,602 | 0 |
| Financing Cash Flow | $-13,153 | $146,381 | $13,908 | $21,084 | $4,271 |
| Exchange Rate Effect | 1 | -6 | N/A | N/A | N/A |
| Beginning Cash Position | 61,353 | 16,873 | 8,699 | 4,879 | 22,322 |
| End Cash Position | 33,997 | 61,353 | 16,873 | 8,699 | 4,879 |
| Net Cash Flow | $-27,356 | $44,480 | $8,173 | $3,821 | $-17,443 |
| Free Cash Flow | |||||
| Operating Cash Flow | 89,192 | -34,585 | -20,745 | -15,396 | -17,287 |
| Capital Expenditure | -1,863 | -235 | -201 | -155 | -460 |
| Free Cash Flow | 87,329 | -34,820 | -20,946 | -15,552 | -17,747 |